top of page

NuvOx Pharma Receives Phase I STTR Grant from NINDS for Preclinical Studies in Stroke

Tucson, AZ, October 12, 2021 --( NuvOx Pharma, a Tucson based biotechnology company, has received a $478,000 NIH Phase I Small Business Technology Transfer (STTR) grant from the National Institute of Neurological Disorders and Stroke (NINDS) under award number R41NS124450. Click here to read more.

Recent Posts

See All

Tucson, AZ, May 16th, 2022 - NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of prepara

Tucson, AZ, May 9th, 2022 – NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases whe

bottom of page